4 results on '"Roberts, Heidi"'
Search Results
2. Dynamic Airway Evaluation with Volume CT: Initial Experience.
- Author
-
Wagnetz, Ute, Roberts, Heidi C., Taebong Chung, Patsios, Demetris, Chapman, Kenneth R., and Paul, Narinder S.
- Subjects
- *
TOMOGRAPHY , *AIRWAY (Anatomy) , *RESPIRATION , *MEDICAL radiography , *DIAGNOSTIC imaging , *RESPIRATORY organs - Abstract
Purpose: The purpose of the study was to prospectively establish the use of a novel multidetector computed tomography unit (MDCT) with 320 × 0.5 detector rows for the evaluation of tracheomalacia by using a dynamic expiratory low-dose technique. Methods: Six adult patients (5 men, I woman; mean age, 53.7 years [37-70 years]) referred for a clinical suspicion of tracheomalacia were studied on a 320-row MDCT unit by using the following parameters: 120 kVp, 40-50 mA, 0.5-second gantry rotation, and z-axis coverage of 160 mm sufficient to cover the thoracic trachea to the proximal bronchi. Image acquisition occurred during a forceful exhalation. The image data set was subject to the following analyses: cross-sectional area of airway lumen at 4 predefined locations (thoracic inlet, aortic arch, carina, and bronchus intermedius) and measurement of airway volume. Results: All 6 patients had evidence of tracheomalacia, the proximal trachea collapsed at a later phase of expiration (3-4 seconds) than the distal trachea (2-3 seconds). The most common region of airway collapse occurred at the level of the aortic arch (5/6 [83%]), Three patients (50%) had diffuse segmental luminal narrowing that involved the tracheobronchial tree. The radiation dose (estimated dose length product, computed tomography console) measured 293.9 mGy in 1 subject and 483.5 mGy in 5 patients. Conclusions: Four-dimensional true isophasic and isovolumetric imaging of the central airways by using 320-row MDCT is a viable technique for the diagnosis of tracheomalacia; it provides a comprehensive assessment of airways dynamic. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
3. Lung Cancer Screening With Low-Dose Computed Tomography: Canadian Experience.
- Author
-
Roberts, Heidi C., Patsios, Demetris, Paul, Narinder S., McGregor, Maureen, Weisbrod, Gordon, TaeBong Chung, Herman, Steven, Boerner, Scott, Waddell, Thomas, Keshavjee, Shafique, Darling, Gail, Pereira, Andre, Kale, Ashwini, Bayanati, Hamid, Sitartchouk, Igor, Ming Tsao, and Shepherd, Frances A,
- Subjects
- *
LUNG cancer , *TOMOGRAPHY , *CIGARETTE smokers , *METASTASIS , *BIOPSY , *MEDICAL research - Abstract
Introduction: In 2003, the Department of Medical Imaging at the University Health Network in Toronto, Ontario, became the first Canadian site of the International Early Lung Cancer Action Program (I-ELCAP). We report the results from the first 1000 baseline studies. Methods: Between June 2003 and December 2005, we enrolled 1000 high-risk smokers (that is, smokers with a history of at least 10 pack years, or the equivalent of one pack daily for 10 years), aged 55 years or older. A low-dose helical computed tomography (CT) (40 to 60 mA, 120 kV) was performed with 1.0 to 1.25 mm collimation. Nodules found at baseline were followed according to the I-ELCAP protocol: 1) no noncalcified nodules (NCNs) or NCNs ≤ 4 mm or nonsolid nodules < 8 mm, annual repeat; 2) NCNs ≥ 5 mm or nonsolid nodules < 8 mm, 3-month follow-up; or 3) nonsolid nodules ≥ 15 mm, antibiotics and 1-month follow-up. Results: The first 1000 study participants were aged 63 years, standard deviation (SD) 6 years, with a smoking history of 38 pack years, SD 22 pack years; 662 (66%) were former smokers, and 338 (34%) were current smokers; 453 (45%) were men, and 547 (55%) were women. Of the participants, 256 (26%) had a positive baseline low-dose computed tomography (LDCT) scan; 227 (23%) were followed after 3 months and 16 (1.6%) after 1 month; 7 (0.7%) received a contrast-enhanced CT and 6 (0.6%) an immediate CT-guided biopsy. Twenty-six invasive procedures were performed: 22 CT-guided biopsies, 1 ultrasound-guided lymph node metastasis biopsy, 1 bronchoscopic biopsy, and 2 surgeries. The malignancy rate of the invasive procedures was 85%. Overall, the malignancy prevalence is 2.2%. Of the malignancies, 20 are lung carcinomas: 19 non-small-cell lung carcinomas (NSCLCs) (14 adenocarcinoma or bronchioalveolar carcinoma [BAC], 4 squamous carcinoma, and 1 large-cell carcinoma) and 1 small-cell carcinoma; 15 (78%) of the NSCLCs are Stage I. Fourteen patients underwent surgery (1 pneumonectomy, 9 lobectomies, and 4 segmentectomies). Conclusion: Our results confirm that LDCT identifies small, early-stage, resectable lung cancer in a high-risk population. [ABSTRACT FROM AUTHOR]
- Published
- 2007
4. Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography.
- Author
-
Kucharczyk, Michael J., Menezes, Ravi J., McGregor, Alexander, Paul, Narinder S., and Roberts, Heidi C.
- Subjects
- *
LUNG tumors , *TOMOGRAPHY , *CHI-squared test , *MEDICAL screening , *RISK assessment , *COMORBIDITY , *COST analysis , *RETROSPECTIVE studies , *DATA analysis software , *DIAGNOSIS - Abstract
Purpose: To assess the prevalence and nature of incidental findings (IF) seen in low-dose computed tomographies (LDCT) from a lung cancer screening study for at-risk individuals. Materials and Methods: Radiology reports from LDCTs of 4073 participants of a lung cancer screening study were retrospectively reviewed for findings other than lung nodules, that is, IFs, which were regarded as actionable. The frequency, nature, and expected cost of these IFs, and their anticipated follow-up were estimated. Results: There were 880 IFs described in 782 study participants (19%); the median age of the participants was 62 years (range, 46-80 years). More IFs were found in men (55%) than in women. The majority of these findings were noncardiovascular (76%), for which imaging was suggested for 74%. There were 7 severe IFs (0.8%) that merited immediate attention. Seven known cancers were diagnosed from follow-ups of the IFs. The majority of IFs (n = 486 [55%]) would require imaging follow-up if clinically indicated, with an estimated total a cost of CAN$45,500 to CAN$51,000 to provide initial diagnostic workup. Conclusion: IFs on lung cancer screening studies are not uncommon and frequently require imaging or other follow-up for definitive diagnoses and to assess their clinical relevance. The implication of IFs has to be considered when determining a cost-effective and ethical protocol for the utilisation of LDCT in a high-risk population. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.